Myovant Sciences Ltd.

NYSE: MYOV · Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM

Myovant Sciences Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2022 FY 2021
Period Ending Mar 31, 2022 Mar 31, 2021
Net Income
-205.98M -255.13M
Depreciation & Amortization
3.07M 2.48M
Stock-Based Compensation
38.93M 53.68M
Other Working Capital
-76.69M 588.34M
Other Non-Cash Items
2.42M 1.17M
Deferred Income Tax
n/a -16.18M
Change in Working Capital
-107M 584.61M
Operating Cash Flow
-268.56M 370.63M
Capital Expenditures
-974K -1.77M
Cash Acquisitions
n/a n/a
Purchase of Investments
-118.75M -63.82M
Sales Maturities Of Investments
101.7M 56.39M
Other Investing Acitivies
n/a n/a
Investing Cash Flow
-18.02M -9.21M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
25.91M 238.04M
Financial Cash Flow
25.91M 238.04M
Net Cash Flow
-260.68M 599.46M
Free Cash Flow
-269.53M 368.86M